Mitoxantrone for paediatric cancer raises toxicity concerns: study

It may be ten times more cardiotoxic than doxorubicin
young child with IV drip in hospital

In paediatric cancer patients, mitoxantrone appears to be at least ten times as cardiotoxic as doxorubicin therapy, while daunorubicin therapy may be less so, according to a large cohort study.